Please wait a minute...
Journal of Neurorestoratology  2018, Vol. 6 Issue (1): 115-119    doi: 10.2147/JN.S147917
Neurorestorative clinical application standards for the culture and quality control of neural progenitor/precursor cells (version 2017)
Shiqing Feng1, Juan Xiao2,3, Fabin Han4, Lin Chen5, Wenyong Gao2,3, Gengsheng Mao2, Hongyun Huang2,3,(✉)
1?International Science and Technology Cooperation Base of Spinal Cord Injury, Department of Orthopedics, Tianjin Medical University General Hospital, Tianjin 300052, China
2?Institute of Neurorestoratology, The General Hospital of Chinese People’s Armed Police Forces, Beijing 100039, China
3 Cell Therapy Center, Beijing Hongtianji Neuroscience Academy, Beijing 100043, China
4?The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng University/Liaocheng People’s Hospital, Liaocheng 252000, China
5?Department of Neurosurgery, Tsinghua University Yuquan Hospital, Beijing 100040, China
Download: PDF (341 KB)      HTML
Export: BibTeX | EndNote (RIS)      


In order to promote the clinical use of neural progenitor or precursor cells for treating neurological diseases and damage, we need to standardize culture procedures for these cells. The Chinese Association of Neurorestoratology put forward these standards for training operators, standardized use and management of materials and equipment, standardized isolation and culture for neural progenitor/precursor cells, and the standardized management in preservation, transport, and related safe operation procedures of the neural progenitors. These cultures and quality control standards also include the Good Manufacturing Practice environment, routine maintenance as well as the monitoring and reporting of the clinical-grade neural progenitor cells. The aim of these standards is to improve the therapeutic efficacy and minimize the possible side effects from lake of quality control.

Key wordsstandardization      cell culture      quality control      neural progenitor cells      neural precursor cells      neurorestoratology     
Received: 01 August 2017      Published: 09 November 2018
Corresponding Authors: Hongyun Huang   
About author: §These authors contributed equally to this work
Cite this article:

Shiqing Feng, Juan Xiao, Fabin Han, Lin Chen, Wenyong Gao, Gengsheng Mao, Hongyun Huang. Neurorestorative clinical application standards for the culture and quality control of neural progenitor/precursor cells (version 2017). Journal of Neurorestoratology, 2018, 6: 115-119.

URL:     OR

[1]   Richards LJ, Kilpatrick TJ, Banlett PF. De novo generation of neuronal cells from the adult mouse brain. Proc Natl Acad Sci USA. 1992, 89(18):8591-8595.
[2]   McKay R. Stem cells in the central nervous system. Science. 1997, 276(5309):66-71.
[3]   Doetsch F, Caillé I, Lim DA, García-Verdugo JM, Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell. 1999, 97(6):703-716.
[4]   Cai Z, Yan Y, Tang Y, et al. Neural stem cells: promising therapy for Alzheimer’s disease. Chin Bull Life Sci. 2008, 20(1):90-94.
[5]   Zhao N, Zhong C, Hong Z. Neurogenesis in the adult subventricular zone. Chin J Clin Neurosci. 2007, 15(01):96-99.
[6]   Davis AA, Temple S. A self-renewing multipotential stem cell in embryonic rat cerebral cortex. Nature. 1994, 372(6503):263-266.
[7]   Jiang X, Wang H, Chen L, et al. Culture and identification of neural stem/progenitor cells from human embryonic subependymal zone by adherent method. Prog Anat Sci. 2011, 16(4):307-310.
[8]   Gao W, Jiang X, Xiao J, et al. The cultivation, cryopreservation and identification of human embryonic striatum tissue neural stem/progenitor cells. Prog Anat Sci. 2015, (6):642-644.
[9]   Bao J, Huang H. Definition of neural stem cells. Chin J Neurosurg. 2008, 24(10):793-796.
[10]   Moviglia GA, Moviglia-Brandolino MT, Varela GS, et al. Feasibility, safety, and preliminary proof of principles of autologous neural stem cell treatment combined with T-cell vaccination for ALS patients. Cell Transplant. 2012, 21():S57-S63.
[11]   Riley J, Glass J, Feldman EL, et al. Intraspinal stem cell transplantation in ALS: a Phase I trial, cervical microinjection and final surgical safety outcomes. Neurosurgery. 2012, 71(2):405-416.
[12]   Feldman EL, Boulis NM, Hur J, et al. Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes. Ann Neurol. 2014, 75(3):363-373.
[13]   Mazzini L, Gelati M, Profico DC, et al. Human neural stem cell transplantation in ALS: initial results from a phase I trial. J Transl Med. 2015, 13:17.
[14]   Nelson PT, Kondziolka D, Wechsler L, et al. Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. Am J Pathol. 2002, 160(4):1201-1206.
[15]   Luan Z, Liu WP, Qu SQ, et al. Treatment of newborns with severe injured brain with transplantation of human neural precursor cells. Zhonghua Er Ke Za Zhi. 2011, 49(6):445-449.
[16]   Chen L, Xi H, Huang H, et al. Multiple cell transplantation based on an intraparenchymal approach for patients with chronic phase stroke. Cell Transplant. 2013, 22():S83-S91.
[17]   Xi H, Chen L, Huang H, et al. Preliminary report of multiple cell therapy for patients with multiple system atrophy. Cell Transplant. 2013, 22():S93-S99.
[18]   Zhou Q, Zhang SZ, Xu RX, Xu K. Neural stem cell transplantation and postoperative management: report of 70 cases. Di Yi Jun Yi Da Xue Xue Bao. 2004, 24(10):1207-1209.
[19]   Guzman R, Schubert M, Keller-Lang D, Huhn SL, Curt A. Human neural stem cell transplantation in chronic SCI: interim results of a Phase I/II trial. Neurosurgery. 2013, 60():185.
[20]   Shin JC, Kim KN, Yoo J, et al. Clinical trial of human fetal brain-derived neural stem/progenitor cell transplantation in patients with traumatic cervical spinal cord injury. Neural Plast. 2015, 2015:630932.
[21]   Curtis E, Gabel BC, Marsala M, Ciacci JD. A phase I, open- label, single-site, safety study of human spinal cord-derived neural stem cell transplantation for the treatment of chronic spinal cord injury. Neurosurgery. 2016, 63():168-169.
[22]   Ren Y, Tian G, Wang H, et al. Quality specification of human embryo olfactory ensheathing cells from olfactory bulb. Chin J Tissue Eng Res. 2008, 12(16):3156-3157.
[23]   Chinese Medical Doctor Association of Neurorestoratology Professional Committee; Chinese Branch of the International Association of Neurorestoratology. Clinical cell therapy guidelines for neurorestoration (China version 2015). Chin J Cell Stem Cell. 2016, 6:1-7.
[24]   Huang H, Chen L, Zou Q, et al. Clinical cell therapy guidelines for neurorestoration (China version 2016). J Neurorestoratol. 2017, 5:39-46.
[25]   Jiang X, Xiao J, Ren Y et al. The influence of 4 degree centigrade conservation on cells activity of rats’ olfactory bulbs derived olfactory ensheathing cells. Prog Anat Sci. 2011, 17(5):424-427.
[26]   Gobbel GT, Kondziolka D, Fellows-Mayle W, Uram M. Cellular transplantation for the nervous system: impact of time after preparation on cell viability and survival. J Neurosurg. 2010, 113(3):666-672.
[1] Hongyun Huang, Lin Chen, Gengsheng Mao, John Bach, Qun Xue, Fabin Han, Xiaoling Guo, Ali Otom, Elena Chernykh, Edgardo Alvarez, Andrey Bryukhovetskiy, Anna Sarnowaska, Xijing He, Milan Dimitrijevic, Ihsan Shanti, Klaus von Wild, Almudena Ramón-Cueto, Ziad Alzoubi, Gustavo Moviglia, Hamid Mobasheri, Adeeb Alzoubi, Wenchuan Zhang. The 2019 yearbook of Neurorestoratology[J]. Journal of Neurorestoratology, 2020, 8(1): 1-11.
[2] Xiaoling Guo, Xin Wang, Yan Li, Bo Zhou, Weidong Chen, Lihua Ren. Olfactory ensheathing cell transplantation improving cerebral infarction sequela: a case report and literature review[J]. Journal of Neurorestoratology, 2019, 7(2): 82-88.
[3] Lin Chen, Wise Young, Gustavo A. Moviglia, Ziad M. Al Zoubi. Summary report of the 11th Annual Conference of International Association of Neurorestoratology (IANR)[J]. Journal of Neurorestoratology, 2019, 7(1): 1-7.
[4] Hongyun Huang, Hari Shanker Sharma, Lin Chen, Hooshang Saberi, Gengsheng Mao. 2018 Yearbook of Neurorestoratology[J]. Journal of Neurorestoratology, 2019, 7(1): 8-17.
[5] Zikuan Leng, Nikhit Kethidi, Allen J. Chang, Lijun Sun, Jingjing Zhai, Yiting Yang, Jianzhong Xu, Xijing He. Muse cells and Neurorestoratology[J]. Journal of Neurorestoratology, 2019, 7(1): 18-25.
[6] Hongyun Huang, Stephen Skaper, Gengsheng Mao, Hooshang Saberi, Shiqing Feng, Sang Ryong Jeon, Lin Chen, Milan Dimitrijevic. 2017 Yearbook of Neurorestoratology[J]. Journal of Neurorestoratology, 2018, 6(1): 67-73.
[7] Qiang Ao, Juan Xiao, Yanqiu Yu, Gengsheng Mao, Qingyan Zou, Wenyong Gao, Hongyun Huang. Standards for the culture and quality control of umbilical cord mesenchymal stromal cells for neurorestorative clinical application (2017)[J]. Journal of Neurorestoratology, 2018, 6(1): 11-15.
[8] Gengsheng Mao, Yunliang Wang, Xiaoling Guo, Jun Liu, Zuncheng Zheng, Lin Chen. Neurorestorative effect of olfactory ensheathing cells and Schwann cells by intranasal delivery for patients with ischemic stroke: design of a multicenter randomized double-blinded placebo-controlled clinical study[J]. Journal of Neurorestoratology, 2018, 6(1): 74-80.
[9] Zhongju Shi, Zhijian Wei, Shiqing Feng, Gustavo Moviglia, Lin Chen, Ping Wu. Highlights for the 10th Annual Conference of the International Association of Neurorestoratology[J]. Journal of Neurorestoratology, 2018, 6(1): 84-87.
[10] Juan Xiao, Lin Chen, Gengsheng Mao, Wenyong Gao, Ming Lu, Xijing He, Hongyun Huang. Neurorestorative clinical application standards for the culture and quality control of olfactory ensheathing cells[J]. Journal of Neurorestoratology, 2017, 5(1): 175-179.
[11] Xiang Li, Guangsheng Li, Keith Dip-Kei Luk, Yong Hu. Neurorestoratology evidence in an animal model with cervical spondylotic myelopathy[J]. Journal of Neurorestoratology, 2017, 5(1): 21-29.
[12] Hongyun Huang, Gengsheng Mao, Shiqing Feng, Lin Chen. 2016 yearbook of neurorestoratology[J]. Journal of Neurorestoratology, 2017, 5(1): 111-115.
[13] Hui Yang, Yu Zhang, Zhaoyan Wang, Wei Lu, Fang Liu, Xin Yu, Xiaoyan Zheng, Yinxiang Yang, Zuo Luan, Suqing Qu. Combined transplantation of neural precursor cells and olfactory ensheathing cells for the treatment of X-linked adrenoleukodystrophy in children[J]. Journal of Neurorestoratology, 2017, 5(1): 93-101.
[14] Hongyun Huang, Lin Chen. Neurorestorative process, law, and mechanisms[J]. Journal of Neurorestoratology, 2015, 3(1): 23-30.
[15] Hongyun Huang, Gengsheng Mao, Lin Chen, Aibing Liu. Progress and challenges with clinical cell therapy in neurorestoratology[J]. Journal of Neurorestoratology, 2015, 3(1): 91-96.